Jiangsu Hengrui (600276) Announces Share Repurchase and Updated Capital Structure

Bulletin Express

Nov 10

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares prior to the transaction. Following this action, the total number of treasury shares rose from 3,069,010 to 3,129,010.

The number of issued shares excluding treasury shares decreased from 6,375,933,264 to 6,375,873,264, while the overall issued share count remained at 6,379,002,274. The repurchase, conducted on the Shanghai Stock Exchange, was carried out for the A Share Employee Stock Ownership Schemes at a highest price of RMB 61.31 and a lowest price of RMB 61, for a total cost of RMB 3,668,376. Company disclosures confirm compliance with applicable regulatory requirements throughout this process.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1183586782"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183586782\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183586782?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183586782","market":"us","top_or_hot":-1,"title":"Jiangsu Hengrui (600276) Announces Share Repurchase and Updated Capital Structure","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares prior to the transaction. Following this action, the total number of treasury shares rose from 3,069,010 to 3,129,010.</p>\n<p>The number of issued shares excluding treasury shares decreased from 6,375,933,264 to 6,375,873,264, while the overall issued share count remained at 6,379,002,274. The repurchase, conducted on the Shanghai Stock Exchange, was carried out for the A Share Employee Stock Ownership Schemes at a highest price of RMB 61.31 and a lowest price of RMB 61, for a total cost of RMB 3,668,376. Company disclosures confirm compliance with applicable regulatory requirements throughout this process.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Hengrui (600276) Announces Share Repurchase and Updated Capital Structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Hengrui (600276) Announces Share Repurchase and Updated Capital Structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-10 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares prior to the transaction. Following this action, the total number of treasury shares rose from 3,069,010 to 3,129,010.</p>\n<p>The number of issued shares excluding treasury shares decreased from 6,375,933,264 to 6,375,873,264, while the overall issued share count remained at 6,379,002,274. The repurchase, conducted on the Shanghai Stock Exchange, was carried out for the A Share Employee Stock Ownership Schemes at a highest price of RMB 61.31 and a lowest price of RMB 61, for a total cost of RMB 3,668,376. Company disclosures confirm compliance with applicable regulatory requirements throughout this process.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1183586782","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183586782","pubTimestamp":1762765480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"江苏恒瑞(600276)公告回购股份及更新资本结构","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) disclosed a repurchase of 60,000 A shares on 10 November 2025, representing approximately 0.0009% of the shares excluding treasury shares prior to the transaction. Following this action, the total number of treasury shares rose from 3,069,010 to 3,129,010.\nThe number of issued shares excluding treasury shares decreased from 6,375,933,264 to 6,375,873,264, while the overall issued share count remained at 6,379,002,274. The repurchase, conducted on the Shanghai Stock Exchange, was carried out for the A Share Employee Stock Ownership Schemes at a highest price of RMB 61.31 and a lowest price of RMB 61, for a total cost of RMB 3,668,376. Company disclosures confirm compliance with applicable regulatory requirements throughout this process.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}